Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.40

0.0%

Nov 28 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trevor john wilkinson who started this subject	3/28/2001 1:33:12 PM
From: Mark Bong	Read Replies (1) of 1475

MEDI 507 BankAmerica Securities Presentation. MEDI 507: Two Phase I/II trials: one with IV and one SubCu- low dose trials have been promising for psoriasis, two Phase II trials (one SubCU and oneIV) for psoriasis will begin soon and end prior to the end of this year. This information is consistent with prior statements. High interest in RA also. I hope that they really are on the fast track now!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next